Aleafia Health Ranks First Based on Key Market
Performance Measures Among all TSXV Listed Companies
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH)
(“
Aleafia Health” or the
“
Company”), has been named the TMX Group’s 2019
TSX Venture 50 top performing company of the year amongst all 2,000
TSX Venture Exchange listed companies. The award was based on three
equally weighted criteria, market capitalization growth, share
price appreciation and trading volume.
WATCH: ALEAFIA HEALTH’S NEW VIDEO – LEARN HOW WE
GROW TOGETHER
“Aleafia Health’s selection as the TSX Venture 50’s top
performing company is a strong validator of our executional
capabilities and relentless focus on providing quality medical
cannabis care to our over 50,000 patients,” said Aleafia Health
Chairman Julian Fantino. “I thank our staff, physicians, patients
and shareholders for their support and role in this significant
achievement.”
“Building on a strong foundation, Aleafia Health has had a
landmark year,” said Aleafia Health CEO Geoff Benic. “In that time,
we have purchased and brought our modern, automated greenhouse to a
grow-ready state, launched our recreational retail and brands
divisions with the Serruya Family and built a base of over 50,000
medical patients.”
“However, we are not content to celebrate past achievements,”
Benic added. “The pending acquisition of Emblem positions Aleafia
Health as a global cannabis health and wellness leader with
national and global distribution in the medical and recreational
sectors. As we integrate Emblem in the coming months, we will
launch industry first, globally scalable cannabis education and
e-commerce platforms, while expanding our recreational sector
product and retail footprint. The best is yet to come.”
LEARN MORE: www.AleafiaHealth.com
For Investor & Media Relations, please
contact:
Nicholas Bergamini, VP, Public
Affairs416-860-5665IR@AleafiaInc.com
About Aleafia Health:
Aleafia Heath, a vertically integrated, national cannabis
company, operates major medical clinic, cannabis cultivation and
R&D divisions. A federally licensed producer and vendor of
cannabis, the company has a planned and fully-funded annual
production capacity of 98,000 kg of dried cannabis flower.
The Company operates medical cannabis clinics staffed by
physicians and nurse practitioners, with over 50,000 patients. The
company is highly differentiated, maintaining the largest medical
cannabis dataset in the world, which it used to develop unique,
proprietary cannabis products and treatment methods.
Aleafia Health is committed to creating sustainable shareholder
value and has been named the top performing company of the year by
the TSX Venture Exchange.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements and
information that are based on the beliefs of management and reflect
the Company's current expectations. When used in this press
release, the words "estimate", "project", "belief", "anticipate",
"intend", "expect", "plan", "predict", "may" or "should" and the
negative of these words or such variations thereon or comparable
terminology are intended to identify forward-looking statements and
information.
The forward-looking statements and information in this press
release includes information relating to the implementation of
Aleafia Health's business plan. Such statements and information
reflect the current view of the Company with respect to risks and
uncertainties that may cause actual results to differ materially
from those contemplated in those forward-looking statements and
information.
By their nature, forward-looking statements involve known and
unknown risks, uncertainties and other factors which may cause our
actual results, performance or achievements, or other future
events, to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. Such factors include, among others, the
following risks: risks associated with the implementation of
Aleafia Health's business plan and matters relating thereto, risks
associated with the cannabis industry, competition, regulatory
change, the need for additional financing, reliance on key
personnel, the potential for conflicts of interest among certain
officers or directors, and the volatility of the Company's common
share price and volume. Forward-looking statements are made based
on management's beliefs, estimates and opinions on the date that
statements are made, and the Company undertakes no obligation to
update forward-looking statements if these beliefs, estimates and
opinions or other circumstances should change. Investors are
cautioned against attributing undue certainty to forward-looking
statements.
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/18bba5e2-aaec-4f67-8282-1563b3fdd9dc
Aleafia Health (TSXV:ALEF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aleafia Health (TSXV:ALEF)
Historical Stock Chart
From Apr 2023 to Apr 2024